• O NAMA

Welcome

Forgot password?

Not a member? Join today

Logo
  • Početna
  • Bolesti
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Leukemije
      • AML
      • ALL
  • Edukacija
    • Prezentacije
      • HLL
      • NHL
      • HL
    • Kvizovi
      • HLL
      • NHL
      • HL
  • Stil života
    • Zdraviji recepti
    • Fizička aktivnost
    • Prevencija
    • Korisni saveti
  • Resursi
    • Video
    • Brošure
    • Infografike
  • Blog
  • English
  • Početna
  • Bolesti
    • Hronična limfocitna leukemija
    • Non hočkinski limfom
    • Hočkinski limfom
    • Leukemije
      • AML
      • ALL
  • Edukacija
    • Prezentacije
      • HLL
      • NHL
      • HL
    • Kvizovi
      • HLL
      • NHL
      • HL
  • Stil života
    • Zdraviji recepti
    • Fizička aktivnost
    • Prevencija
    • Korisni saveti
  • Resursi
    • Video
    • Brošure
    • Infografike
  • Blog
  • English

Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome after a stem cell transplant

22 Oct 2018
  • maja
  • Uncategorized

Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome after a stem cell transplant

Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome after a stem cell transplant This study evaluated the risk

Read More

22 Oct 2018
  • maja
  • Uncategorized

Hodgkin Lymphoma Above and Below the Diaphragm: Are The Outcomes Different?

Hodgkin Lymphoma Above and Below the Diaphragm: Are The Outcomes Different? This study investigated the development of Hodgkin lymphoma (HL)

Read More

22 Oct 2018
  • maja
  • Hronična limfocitna leukemija

Chlorambucil, rituximab and lenalidomide combination treatment for patients with chronic lymphocytic leukemia

Chlorambucil, rituximab and lenalidomide combination treatment for patients with chronic lymphocytic leukemia This study aimed to evaluate the

Read More

22 Oct 2018
  • maja
  • Hronična limfocitna leukemija

Evaluating the safety of ibrutinib in leukemia and lymphoma

Evaluating the safety of ibrutinib in leukemia and lymphoma This study looked at the evidence for the safety of ibrutinib (Imbruvica) in the

Read More

13 Apr 2018
  • maja
  • Nehočkinski limfom

Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone

Diffuse large B-cell lymphoma: 10 years’ real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and

Read More

  • 1
  • 2
  • 3
  • …
  • 5

Izradu platforme podržala kompanija

KONTAKT

Udruženje LIPA
+ 381 60 0 222 317
majaklipa@gmail.com
www.lipa.org.rs

Budite u toku sa najnovijim dešavanjima. Prijavite se

© Copyright LIPA 2017